A phase 1 study of lenvatinib, multiple receptor tyrosine kinase inhibitor, in Japanese patients with advanced solid tumors

Por Nakamichi, Shinji, Nokihara, Hiroshi, Yamamoto, Noboru, Yamada, Yasuhide, Honda, Kazunori, Tamura, Yosuke, Wakui, Hiroshi, Sasaki, Tatsuya, Yusa, Wataru, Fujino, Katsuki, Tamura, Tomohide
Publicado no Cancer Chemother Pharmacol (2015)

Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine‐refractory differentiated thyroid cancer

Por Kiyota, Naomi, Schlumberger, Martin, Muro, Kei, Ando, Yuichi, Takahashi, Shunji, Kawai, Yasukazu, Wirth, Lori, Robinson, Bruce, Sherman, Steven, Suzuki, Takuya, Fujino, Katsuki, Gupta, Anubha, Hayato, Seiichi, Tahara, Makoto
Publicado no Cancer Sci (2015)

Lenvatinib for Anaplastic Thyroid Cancer

Por Tahara, Makoto, Kiyota, Naomi, Yamazaki, Tomoko, Chayahara, Naoko, Nakano, Kenji, Inagaki, Lina, Toda, Kazuhisa, Enokida, Tomohiro, Minami, Hironobu, Imamura, Yoshinori, Sasaki, Tatsuya, Suzuki, Takuya, Fujino, Katsuki, Dutcus, Corina E., Takahashi, Shunji
Publicado no Front Oncol (2017)